Samal, Zuhara A.

HRN: 06-81-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/07/2025
11/14/2025
IV
4.5g
Q8h
DM Foot
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines